Inovio Pharma drops on stock offering plans

By Reuters News

** Inovio Pharmaceuticals' INO.O shares down 22.1% to $1.13 in extended trading as it seeks equity raise

** Biotech firm announces stock offering without disclosing deal size

** Jefferies and Piper Sandler joint bookrunners

** INO shares more than tripled to close at $1.89 on Mon after the US FDA approved co's rare throat disease treatment, branded as Voceryq

** Plymouth Meeting, Pennsylvania-based INO has ~110.2 mln shares outstanding as of Sept 30, per the prospectus

** INO shares finished down 10.5% at $1.45 on Thurs

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk